AGI Infra Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 7:36 pm

Quick Insight

AGI Infra Ltd, operating in the Construction, Contracting, and Engineering sector, currently shows a Price of 1,158 with a Market Cap of 2,829 Cr. The company's financial metrics reveal a P/E ratio of 39.2 and robust returns with ROE at 25.7% and ROCE at 21.8%. Operating profit margin stands at 33%, supported by a Net Profit of 67 Cr. However, the company's high CCC of 1,698 days and elevated P/BV of 7.09x warrant caution, especially considering the significant borrowings of ₹137 Cr. Investors should closely monitor liquidity risks given the ICR of 8.30x.

Competitors of AGI Infra Ltd

All Competitor Stocks of AGI Infra Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:20 am

Below is a detailed analysis of the quarterly data for AGI Infra Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 92.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2025) to 92.00 Cr., marking an increase of 9.00 Cr..
• For Expenses, as of Jun 2025, the value is 61.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 68.00 Cr. (Mar 2025) to 61.00 Cr., marking a decrease of 7.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 14.00 Cr..
• For OPM %, as of Jun 2025, the value is 33.00%. The value appears strong and on an upward trend. It has increased from 19.00% (Mar 2025) to 33.00%, marking an increase of 14.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 12.00 Cr..
• For Tax %, as of Jun 2025, the value is 18.00%. The value appears to be increasing, which may not be favorable. It has increased from -27.00% (Mar 2025) to 18.00%, marking an increase of 45.00%.
• For Net Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 8.19. The value appears strong and on an upward trend. It has increased from 6.44 (Mar 2025) to 8.19, marking an increase of 1.75.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:10 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:58 pm

Below is a detailed analysis of the balance sheet data for AGI Infra Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 283.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2024) to 283.00 Cr., marking an increase of 71.00 Cr..
• For Borrowings, as of Mar 2025, the value is 137.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 138.00 Cr. (Mar 2024) to 137.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 764.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 717.00 Cr. (Mar 2024) to 764.00 Cr., marking an increase of 47.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,196.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,080.00 Cr. (Mar 2024) to 1,196.00 Cr., marking an increase of 116.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 275.00 Cr.. The value appears strong and on an upward trend. It has increased from 251.00 Cr. (Mar 2024) to 275.00 Cr., marking an increase of 24.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 921.00 Cr.. The value appears strong and on an upward trend. It has increased from 828.00 Cr. (Mar 2024) to 921.00 Cr., marking an increase of 93.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,196.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,080.00 Cr. (Mar 2024) to 1,196.00 Cr., marking an increase of 116.00 Cr..

Notably, the Reserves (283.00 Cr.) exceed the Borrowings (137.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for AGI Infra Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 5.00, marking a decrease of 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 27.28. This value is within the healthy range. It has decreased from 42.64 (Mar 24) to 27.28, marking a decrease of 15.36.
• For Diluted EPS (Rs.), as of Mar 25, the value is 27.28. This value is within the healthy range. It has decreased from 42.64 (Mar 24) to 27.28, marking a decrease of 15.36.
• For Cash EPS (Rs.), as of Mar 25, the value is 34.77. This value is within the healthy range. It has decreased from 52.17 (Mar 24) to 34.77, marking a decrease of 17.40.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 120.65. It has decreased from 183.89 (Mar 24) to 120.65, marking a decrease of 63.24.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 120.65. It has decreased from 183.89 (Mar 24) to 120.65, marking a decrease of 63.24.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 132.96. It has decreased from 239.28 (Mar 24) to 132.96, marking a decrease of 106.32.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 43.02. This value is within the healthy range. It has decreased from 69.25 (Mar 24) to 43.02, marking a decrease of 26.23.
• For PBIT / Share (Rs.), as of Mar 25, the value is 35.53. This value is within the healthy range. It has decreased from 59.72 (Mar 24) to 35.53, marking a decrease of 24.19.
• For PBT / Share (Rs.), as of Mar 25, the value is 30.35. This value is within the healthy range. It has decreased from 53.76 (Mar 24) to 30.35, marking a decrease of 23.41.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 27.28. This value is within the healthy range. It has decreased from 42.64 (Mar 24) to 27.28, marking a decrease of 15.36.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 27.28. This value is within the healthy range. It has decreased from 42.64 (Mar 24) to 27.28, marking a decrease of 15.36.
• For PBDIT Margin (%), as of Mar 25, the value is 32.35. This value is within the healthy range. It has increased from 28.93 (Mar 24) to 32.35, marking an increase of 3.42.
• For PBIT Margin (%), as of Mar 25, the value is 26.72. This value exceeds the healthy maximum of 20. It has increased from 24.95 (Mar 24) to 26.72, marking an increase of 1.77.
• For PBT Margin (%), as of Mar 25, the value is 22.82. This value is within the healthy range. It has increased from 22.46 (Mar 24) to 22.82, marking an increase of 0.36.
• For Net Profit Margin (%), as of Mar 25, the value is 20.52. This value exceeds the healthy maximum of 10. It has increased from 17.82 (Mar 24) to 20.52, marking an increase of 2.70.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 20.52. This value exceeds the healthy maximum of 20. It has increased from 17.82 (Mar 24) to 20.52, marking an increase of 2.70.
• For Return on Networth / Equity (%), as of Mar 25, the value is 22.61. This value is within the healthy range. It has decreased from 23.18 (Mar 24) to 22.61, marking a decrease of 0.57.
• For Return on Capital Employeed (%), as of Mar 25, the value is 22.07. This value is within the healthy range. It has decreased from 26.25 (Mar 24) to 22.07, marking a decrease of 4.18.
• For Return On Assets (%), as of Mar 25, the value is 5.57. This value is within the healthy range. It has increased from 4.82 (Mar 24) to 5.57, marking an increase of 0.75.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.33. This value is within the healthy range. It has increased from 0.23 (Mar 24) to 0.33, marking an increase of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has decreased from 0.61 (Mar 24) to 0.46, marking a decrease of 0.15.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.28. It has decreased from 0.31 (Mar 24) to 0.28, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 1.13. This value is below the healthy minimum of 1.5. It has increased from 1.03 (Mar 24) to 1.13, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 1. It has decreased from 0.20 (Mar 24) to 0.11, marking a decrease of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.44, marking an increase of 0.44.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.34 (Mar 24) to 0.00, marking a decrease of 2.34.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.91 (Mar 24) to 0.00, marking a decrease of 1.91.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.66 (Mar 24) to 0.00, marking a decrease of 97.66.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.09 (Mar 24) to 0.00, marking a decrease of 98.09.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 8.30. This value is within the healthy range. It has decreased from 11.62 (Mar 24) to 8.30, marking a decrease of 3.32.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.27. This value is within the healthy range. It has decreased from 8.16 (Mar 24) to 6.27, marking a decrease of 1.89.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,199.03. It has increased from 1,142.38 (Mar 24) to 2,199.03, marking an increase of 1,056.65.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.77. This value exceeds the healthy maximum of 3. It has increased from 3.91 (Mar 24) to 6.77, marking an increase of 2.86.
• For EV / EBITDA (X), as of Mar 25, the value is 20.92. This value exceeds the healthy maximum of 15. It has increased from 13.50 (Mar 24) to 20.92, marking an increase of 7.42.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.43. This value exceeds the healthy maximum of 3. It has increased from 3.78 (Mar 24) to 6.43, marking an increase of 2.65.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 97.65 (Mar 24) to 0.00, marking a decrease of 97.65.
• For Price / BV (X), as of Mar 25, the value is 7.09. This value exceeds the healthy maximum of 3. It has increased from 4.92 (Mar 24) to 7.09, marking an increase of 2.17.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.43. This value exceeds the healthy maximum of 3. It has increased from 3.78 (Mar 24) to 6.43, marking an increase of 2.65.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness